Biogen, Inc. - Company Profile and SWOT Analysis

May 2026 | 53 pages | ID: B92ACECF79BEN
MarketLine

Abstracts

Summary

Biogen, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Biogen, Inc. (Biogen) discovers, develops, manufactures, and commercializes therapies in the areas of hematology, neurology and immunology. The company develops therapies for multiple sclerosis, neuroimmunology movement disorders, including Parkinson's disease, neuromuscular disorders and Alzheimer's disease and dementia, including amyotrophic lateral sclerosis and spinal muscular atrophy. It also develops and manufactures biosimilars of advanced biologics. The company markets its products under Flixabi, Tecfidera, Avonex, Benepali, Imraldi, Spinraza, Tysabri, Eylea, Gazyva, Fampyra, Plegridy and Fumaderm brand names. Biogen has business operations in the North America, Asia and Europe. The company is headquartered in Weston, Massachusetts, the US.

Scope

• Detailed information on Biogen, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
• Intelligence on Biogen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Biogen, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Biogen, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Biogen, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Biogen, Inc.'s business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Biogen, Inc.: Company Overview
Biogen, Inc.: Overview and Key Facts
Biogen, Inc.: Overview
Biogen, Inc.: Key Facts
Biogen, Inc.: Key Employees
Biogen, Inc.: Key Employee Biographies
Biogen, Inc.: Major Products and Services
Biogen, Inc.: Management Statement
Biogen, Inc.: Key Competitors
Biogen, Inc.: Company Analysis
Biogen, Inc.: Business Description
Biogen, Inc.: SWOT Analysis
Biogen, Inc.: SWOT Overview
Biogen, Inc.: Strengths
Biogen, Inc.: Weaknesses
Biogen, Inc.: Opportunities
Biogen, Inc.: Threats
Biogen, Inc.: Corporate Financial Deals Activity
Biogen, Inc.: Financial Deals Overview
Biogen, Inc.: Targets and Partners
Biogen, Inc.: Top Deals 2022 - 2026YTD*
Biogen, Inc.: Advisors
Biogen, Inc.: Top Legal Advisors
Biogen, Inc.: Top Financial Advisors
Biogen, Inc.: Mergers and Acquisitions
Biogen, Inc.: Corporate Venturing
Biogen, Inc.: Capital Raising
Biogen, Inc.: Partnership
Biogen, Inc.: Divestments
Biogen, Inc.: Recent Developments
Biogen, Inc.: News and Events Summary
Biogen, Inc.: Business Expansion
Biogen, Inc.: Contracts
Biogen, Inc.: Corporate Governance
Biogen, Inc.: Market Developments
Biogen, Inc.: Research & Development
Biogen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Key Competitors
Table 4: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Biogen, Inc.: M&A Activity by Geography (TTM*)
Table 6: Biogen, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Table 7: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Biogen, Inc.: Targets and Partners
Table 9: Biogen, Inc.: Top Deals 2022 - 2026YTD*
Table 10: Biogen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Biogen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Biogen, Inc.: M&A Volume and Value Trend (2022 - YTD*2026)
Table 13: Biogen, Inc.: M&A Activity by Geography (2022 - YTD*2026)
Table 14: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026)
Table 15: Biogen, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026)
Table 16: Biogen, Inc.: Capital Raising by Deal Type (2022 - YTD*2026)
Table 17: Biogen, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Table 18: Biogen, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Table 19: Biogen, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
Table 20: Biogen, Inc.: Divestments by Geography (2022 - YTD*2026)
Table 21: Biogen, Inc.: News and Events Summary
Table 22: Biogen, Inc.: Business Expansion
Table 23: Biogen, Inc.: Contracts
Table 24: Biogen, Inc.: Corporate Governance
Table 25: Biogen, Inc.: Market Developments
Table 26: Biogen, Inc.: Research & Development
Table 27: Biogen, Inc.: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Biogen, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Biogen, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Figure 4: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Biogen, Inc.: M&A Volume and Value Trend (2022 - YTD*2026)
Figure 6: Biogen, Inc.: M&A Activity by Geography (2022 - YTD*2026)
Figure 7: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2022 - YTD*2026)
Figure 8: Biogen, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026)
Figure 9: Biogen, Inc.: Capital Raising by Deal Type (2022 - YTD*2026)
Figure 10: Biogen, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Figure 11: Biogen, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Figure 12: Biogen, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
Figure 13: Biogen, Inc.: Divestments by Geography (2022 - YTD*2026)